← Back to Search

Corticosteroid

Carpal Tunnel Syndrome - Randomized Clinical Trial Evaluating Effectiveness of Ultrasound in Corticosteroid Injection (STC-EI Trial)

N/A
Waitlist Available
Led By Alessandra Bruns, Md, FRCPC
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
All Individual Drugs Already Approved
No Placebo-Only Group
Approved for 50 Other Conditions

Summary

The objective of this study is to evaluate the efficacy of ultrasound guided corticosteroid injection in reducing symptoms caused by carpal tunnel syndrome.

Eligible Conditions
  • Carpal Tunnel Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Boston Carpal Tunnel Syndrome Questionnaire - Symptom Severity Scale
Secondary study objectives
Boston Carpal Tunnel Syndrome Questionnaire - Functional Status Scale
Global Rating of Change
Numeric Pain Rating Scale
Other study objectives
Trial group assignment - Assessor
Trial group assignment - Patient

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Approved for 50 Other Conditions
This treatment demonstrated efficacy for 50 other conditions.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Ultrasound guided injectionExperimental Treatment2 Interventions
Ultrasound guided injection of 40 mg of methylprednisolone
Group II: Blind injectionActive Control1 Intervention
Blind injection of 40 mg of methylprednisolone
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Methylprednisolone
FDA approved
Ultrasound
2013
Completed Phase 1
~4090

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor
306 Previous Clinical Trials
77,534 Total Patients Enrolled
1 Trials studying Carpal Tunnel Syndrome
180 Patients Enrolled for Carpal Tunnel Syndrome
Alessandra Bruns, Md, FRCPCPrincipal InvestigatorUniversité de Sherbrooke
~4 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top